167 related articles for article (PubMed ID: 38582956)
21. Integrative analysis revealed a correlation of PIAS family genes expression with prognosis, immunomodulation and chemotherapy.
Zhang Q; Zhang J; Lan T; He J; Lei B; Wang H; Mei Z; Lv C
Eur J Med Res; 2024 Mar; 29(1):195. PubMed ID: 38528630
[TBL] [Abstract][Full Text] [Related]
22. Macrophage migration inhibitory factor and CD74 regulate macrophage chemotactic responses via MAPK and Rho GTPase.
Fan H; Hall P; Santos LL; Gregory JL; Fingerle-Rowson G; Bucala R; Morand EF; Hickey MJ
J Immunol; 2011 Apr; 186(8):4915-24. PubMed ID: 21411731
[TBL] [Abstract][Full Text] [Related]
23. Pan-cancer analyses of clinical prognosis, immune infiltration, and immunotherapy efficacy for TRPV family using multi-omics data.
Shen C; Fu C; Suo Y; Li K; Zhang Z; Yang S; Zhang Y; Lin Y; Li Z; Wu Z; Huang S; Chen H; Fan Z; Hu H
Heliyon; 2023 Jun; 9(6):e16897. PubMed ID: 37346342
[TBL] [Abstract][Full Text] [Related]
24. Novel association between CD74 polymorphisms and hematologic toxicity in patients with NSCLC after platinum-based chemotherapy.
Tan X; Wu Q; Cai Y; Zhao X; Wang S; Gao Z; Yang Y; Li X; Qian J; Wang J; Su B; Chen H; Han B; Jiang G; Lu D
Clin Lung Cancer; 2014 Jan; 15(1):67-78.e12. PubMed ID: 24220096
[TBL] [Abstract][Full Text] [Related]
25. Comprehensive Multiomic Analysis Identified TUBA1C as a Potential Prognostic Biological Marker of Immune-Related Therapy in Pan-Cancer.
Zou Y; Wang G; Fan M
Comput Math Methods Med; 2022; 2022():9493115. PubMed ID: 36466547
[TBL] [Abstract][Full Text] [Related]
26. Expression, prognosis value, and immune infiltration of lncRNA ASB16-AS1 identified by pan-cancer analysis.
Wu L; Liao W; Wang X; Zhao Y; Pang J; Chen Y; Yang H; He Y
Bioengineered; 2021 Dec; 12(2):10302-10318. PubMed ID: 34709970
[TBL] [Abstract][Full Text] [Related]
27. A multi-omics analysis reveals CLSPN is associated with prognosis, immune microenvironment and drug resistance in cancers.
Chen Y; Wen H; Li Y; Han Y; Tan J; Guo C; Cai C; Liu P; Peng Y; Liu Y; Wang X; Zeng S; Feng Z; Shen H
Biol Proced Online; 2023 Jun; 25(1):16. PubMed ID: 37268895
[TBL] [Abstract][Full Text] [Related]
28. Identify the immune characteristics and immunotherapy value of CD93 in the pan-cancer based on the public data sets.
Guo A; Zhang J; Tian Y; Peng Y; Luo P; Zhang J; Liu Z; Wu W; Zhang H; Cheng Q
Front Immunol; 2022; 13():907182. PubMed ID: 36389798
[TBL] [Abstract][Full Text] [Related]
29. Analysis of Bulk RNA Sequencing Data Reveals Novel Transcription Factors Associated With Immune Infiltration Among Multiple Cancers.
Liu L; Zhao Q; Cheng C; Yi J; Sun H; Wang Q; Quan W; Xue Y; Sun L; Cong X; Zhang Y
Front Immunol; 2021; 12():644350. PubMed ID: 34489925
[TBL] [Abstract][Full Text] [Related]
30. Comprehensive landscape of the miRNA-regulated prognostic marker LAYN with immune infiltration and stemness in pan-cancer.
Jiawen W; Jinfu W; Jianyong L; Yaoguang Z; Jianye W
J Cancer Res Clin Oncol; 2023 Oct; 149(13):10989-11011. PubMed ID: 37335337
[TBL] [Abstract][Full Text] [Related]
31. Pan-cancer analysis predicts CANT1 as a potential prognostic, immunologic biomarker.
Yang W; Liu Z; Liu T
Cell Signal; 2024 May; 117():111107. PubMed ID: 38369265
[TBL] [Abstract][Full Text] [Related]
32. Large-Scale Single-Cell and Bulk Sequencing Analyses Reveal the Prognostic Value and Immune Aspects of CD147 in Pan-Cancer.
Zhang J; Wang Z; Zhang X; Dai Z; Zhi-Peng W; Yu J; Peng Y; Wu W; Zhang N; Luo P; Zhang J; Liu Z; Feng S; Zhang H; Cheng Q
Front Immunol; 2022; 13():810471. PubMed ID: 35464411
[TBL] [Abstract][Full Text] [Related]
33. XRCC1: a potential prognostic and immunological biomarker in LGG based on systematic pan-cancer analysis.
Wang G; Li Y; Pan R; Yin X; Jia C; She Y; Huang L; Yang G; Chi H; Tian G
Aging (Albany NY); 2024 Jan; 16(1):872-910. PubMed ID: 38217545
[TBL] [Abstract][Full Text] [Related]
34. Homologous repair deficiency-associated genes in invasive breast cancer revealed by WGCNA co-expression network analysis and genetic perturbation similarity analysis.
Chen H; Liu Y; Yin Z; Chen H; Wang Y; Qian Y
Cell Cycle; 2023 May; 22(9):1077-1100. PubMed ID: 36757135
[TBL] [Abstract][Full Text] [Related]
35. CD74-Downregulation of Placental Macrophage-Trophoblastic Interactions in Preeclampsia.
Przybyl L; Haase N; Golic M; Rugor J; Solano ME; Arck PC; Gauster M; Huppertz B; Emontzpohl C; Stoppe C; Bernhagen J; Leng L; Bucala R; Schulz H; Heuser A; Weedon-Fekjær MS; Johnsen GM; Peetz D; Luft FC; Staff AC; Müller DN; Dechend R; Herse F
Circ Res; 2016 Jun; 119(1):55-68. PubMed ID: 27199465
[TBL] [Abstract][Full Text] [Related]
36. Comprehensive Multi-Omics Identification of Interferon-γ Response Characteristics Reveals That RBCK1 Regulates the Immunosuppressive Microenvironment of Renal Cell Carcinoma.
Xu W; Tao J; Zhu W; Liu W; Anwaier A; Tian X; Su J; Shi G; Huang H; Wei G; Li C; Qu Y; Zhang H; Ye D
Front Immunol; 2021; 12():734646. PubMed ID: 34795663
[TBL] [Abstract][Full Text] [Related]
37. Tumor Necrosis Factor α-Dependent Lung Inflammation Promotes the Progression of Lung Adenocarcinoma Originating From Alveolar Type II Cells by Upregulating MIF-CD74.
Cao L; Wang X; Liu X; Meng W; Guo W; Duan C; Liang X; Kang L; Lv P; Lin Q; Zhang R; Zhang X; Shen H
Lab Invest; 2023 Mar; 103(3):100034. PubMed ID: 36925198
[TBL] [Abstract][Full Text] [Related]
38. CXCL11 Correlates with Immune Infiltration and Impacts Patient Immunotherapy Efficacy: A Pan-Cancer Analysis.
Li Y; Han S; Wu B; Zhong C; Shi Y; Lv C; Fu L; Zhang Y; Lang Q; Liang Z; Yu Y; Tian Y
Front Immunol; 2022; 13():951247. PubMed ID: 35935945
[TBL] [Abstract][Full Text] [Related]
39. CD74 regulates complexity of tumor cell HLA class II peptidome in brain metastasis and is a positive prognostic marker for patient survival.
Zeiner PS; Zinke J; Kowalewski DJ; Bernatz S; Tichy J; Ronellenfitsch MW; Thorsen F; Berger A; Forster MT; Muller A; Steinbach JP; Beschorner R; Wischhusen J; Kvasnicka HM; Plate KH; Stefanović S; Weide B; Mittelbronn M; Harter PN
Acta Neuropathol Commun; 2018 Mar; 6(1):18. PubMed ID: 29490700
[TBL] [Abstract][Full Text] [Related]
40. RelB is a potential molecular biomarker for immunotherapy in human pan-cancer.
Wu J; Yu X; Zhu H; Chen P; Liu T; Yin R; Qiang Y; Xu L
Front Mol Biosci; 2023; 10():1178446. PubMed ID: 37388242
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
